A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects
NCT00334659
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
apricitabine
Sponsor
Avexa